The future of AD clinical trials with the advent of anti-amyloid therapies: An CTAD Task Force report
The Journal of Prevention of Alzheimer's Disease
Open Access Publication
Rights and Permissions
Delrieu, J., Bateman, R.J., Touchon, J. et al. The Future of AD Clinical Trials with the Advent of Anti-Amyloid Therapies: An CTAD Task Force Report. J Prev Alzheimers Dis 9, 393–399 (2022). https://doi.org/10.14283/jpad.2022.48 This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
Delrieu, J; Bateman, R J; Touchon, J; Sabbagh, M; and Cummings, J, "The future of AD clinical trials with the advent of anti-amyloid therapies: An CTAD Task Force report." The Journal of Prevention of Alzheimer's Disease. 9, 3. 393 - 399. (2022).